Abstract
Natural products drug discovery has allowed the identification of many biologically active compounds from plants, microbial species, and marine organisms. A significant number of these compounds are currently used as drugs in therapeutic protocols, while other naturally occurring chemical entities gave suggestions for designing nonnatural-productderived drugs or have been modified in their structure to have semi-synthetic analogues. In the last decade, experimental evidence that correlated the aberrant activation of the Hedgehog (Hh) signaling pathway with many types of cancer, prompted the researchers to check natural compounds for their ability to modulate this signaling cascade. As a result, many compounds from natural sources showed inhibitory activity toward one or more of the Hh signaling pathway components, such as Smoothened (Smo) and the downstream effectors Gli. On the other hand, only a few natural compounds were able to stimulate the same pathway. This review reports a survey of the compounds extracted from natural sources (especially plants) that showed activity in inhibiting the Hh signaling machinery by interfering with its components.
Keywords: Apoptosis, bioactivity-directed fractionation, cancer cells, cytotoxicity, Gli1-mediated transcriptional activity, Hedgehog inhibitors, Hedgehog signaling pathway, naturally occurring compounds, small molecules, structure- activity relationship analysis, synthesis, tetracycline-regulated Gli1 expression assay.
Current Medicinal Chemistry
Title:Targeting the Hedgehog Signaling Pathway with Small Molecules from Natural Sources
Volume: 22 Issue: 35
Author(s): E. Petricci and F. Manetti
Affiliation:
Keywords: Apoptosis, bioactivity-directed fractionation, cancer cells, cytotoxicity, Gli1-mediated transcriptional activity, Hedgehog inhibitors, Hedgehog signaling pathway, naturally occurring compounds, small molecules, structure- activity relationship analysis, synthesis, tetracycline-regulated Gli1 expression assay.
Abstract: Natural products drug discovery has allowed the identification of many biologically active compounds from plants, microbial species, and marine organisms. A significant number of these compounds are currently used as drugs in therapeutic protocols, while other naturally occurring chemical entities gave suggestions for designing nonnatural-productderived drugs or have been modified in their structure to have semi-synthetic analogues. In the last decade, experimental evidence that correlated the aberrant activation of the Hedgehog (Hh) signaling pathway with many types of cancer, prompted the researchers to check natural compounds for their ability to modulate this signaling cascade. As a result, many compounds from natural sources showed inhibitory activity toward one or more of the Hh signaling pathway components, such as Smoothened (Smo) and the downstream effectors Gli. On the other hand, only a few natural compounds were able to stimulate the same pathway. This review reports a survey of the compounds extracted from natural sources (especially plants) that showed activity in inhibiting the Hh signaling machinery by interfering with its components.
Export Options
About this article
Cite this article as:
Petricci E. and Manetti F., Targeting the Hedgehog Signaling Pathway with Small Molecules from Natural Sources, Current Medicinal Chemistry 2015; 22 (35) . https://dx.doi.org/10.2174/0929867322666150904111042
DOI https://dx.doi.org/10.2174/0929867322666150904111042 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GLP-1 Targeted Novel 3-phenyl-7-hydroxy Substituted Coumarins
Mitigate STZ-induced Pancreatic Damage and Improve Glucose
Homeostasis in OGTT Method
Protein & Peptide Letters State of the Heart: CMR in Coronary Artery Disease
Current Medical Imaging Other Activities
Current Bioactive Compounds An Updated Unified Pharmacophore Model of the Benzodiazepine Binding Site on γ-Aminobutyric Acida Receptors: Correlation with Comparative Models
Current Medicinal Chemistry Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients
Current Pharmaceutical Design Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry Association of Genetic Variation with Pneumonia
Current Respiratory Medicine Reviews The Asymmetric [C+NC+CC] Coupling Reaction: Development and Application to Natural Product Synthesis
Current Organic Synthesis Stem Cell Therapy in Heart Diseases: A Review of Selected New Perspectives,Practical Considerations and Clinical Applications
Current Cardiology Reviews Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Current Medicinal Chemistry Acetylcholinesterase: Molecular Modeling with the Whole Toolkit
Current Topics in Medicinal Chemistry In Vitro Solubility Assays in Drug Discovery
Current Drug Metabolism Molecular Mechanisms Regulating mRNA Stability: Physiological and Pathological Significance
Current Genomics Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Cognitive Assessment of Dementia: The Need for an Inclusive Design Tool
Current Alzheimer Research Development of Integrase Inhibitors of Quinolone Acid Derivatives for Treatment of AIDS: An Overview
Mini-Reviews in Medicinal Chemistry Microwave Assisted Green Synthesis of Benzimidazole Derivatives and Evaluation of Their Anticonvulsant Activity
Current Microwave Chemistry The Chemical Biology of Immunophilin Ligands
Current Medicinal Chemistry Medicinal Attributes of Imidazo[1,2-a]pyridine Derivatives: An Update
Current Topics in Medicinal Chemistry Sonication Assisted One-Pot Synthesis of Substituted Imidazopyridine from Styrene in Water
Current Organic Synthesis